News Snapshot:
China issues conditional approval for domestic HIV drug for COVID-19 treatment; officials vow to ramp up development, approval work of COVID-19 therapies Photo: VCG The Chinese National Medical Products Administration (NMPA) said on Monday that it had granted conditional approval to a domestically developed oral drug for COVID-19 treatment. The announcement was made on the same day that NMPA officials vowed to accelerate the development and approval of COVID-19 therapies. Azvudine, produced by Genuine Biotech Limited, based in Central China Henan, has been approved to treat adults who show normal symptoms after a COVID-19 infection, according to the announcement by...
